Influenza virus vaccination and booster in B-cell chronic lymphocytic leukaemia patients

European Journal of Internal Medicine

Volumn 12, Issue 5, 2001, Pages 420-424

  Van der Velden, A M T ^a   Mulder, A H L ^a   Hartkamp, A ^a   Diepersloot, R J A ^b   Van Velzen Blad, H ^a   Biesma, D H ^a  

^a ST ANTONIUS HOSPITAL   (Netherlands)

^b DEPARTMENT OF SURGERY   (Netherlands)

Author keywords

Haematological neoplasms; Immunisation; Influenza vaccine

Indexed keywords

HEMAGGLUTINATION INHIBITING ANTIBODY; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; INFLUENZA VACCINE;

ADULT; AGED; ANTIBODY RESPONSE; ANTIBODY TITER; ARTICLE; B CELL LEUKEMIA; CANCER CHEMOTHERAPY; CHRONIC LYMPHATIC LEUKEMIA; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE DURATION; DRUG EFFECT; FEMALE; HUMAN; IMMUNE RESPONSE; INFLUENZA VACCINATION; MALE;

EID: 0034846404     PISSN: 09536205     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0953-6205(01)00149-2     Document Type: Article

References (27)

1. Influenza vaccines
2. Impaired serum antibody response to inactivated influenza A and B vaccine in cancer patients
3. Effect of cancer chemotherapy on the immune response to influenza virus vaccine: Review of published studies
4. Influenza subtype-specific immunoglobulin A and G responses after booster versus one double-dose vaccination in haemodialysis patients
5. Humoral immune response after influenza vaccination with booster in patients with type 1 diabetes mellitus
6. Immunisation of elderly people with two doses of influenza vaccine
7. Infection and immunity in chronic lymphocytic leukaemia
8. Immunisation with influenza vaccine in patients with haematological malignant disease
9. Clinical staging of chronic lymphocytic leukaemia
10. Influenza virus vaccine in B-cell chronic lymphocytic leukaemia patients
11. Responses of patients with neoplastic diseases to influenza virus vaccine
12. Immunogenicity of influenza vaccine in patients with hemato-oncological disorders
13. Influenza immunisation of adult patients with malignant diseases
14. Active hepatitis B vaccination of dialysis patients and medical staff
15. Assessment of inactivated influenza A vaccine after three outbreaks of influenza A at Christ's Hospital
16. Protection against influenza after annually repeated vaccination
17. The plea against annual influenza vaccination? 'The Hoskin's Paradox' revisited
18. Quality and quantity of the humoral immune response in healthy elderly and young subjects after annually repeated influenza vaccination
19. Influenza vaccination in patients with Graves' disease. Clinical reactions, immunogenicity and protection
20. Immunogenicity and reactogenicity of two doses of a trivalent influenza split vaccine, an open randomised study in healthy, unprotected, adult volunteers
21. Serum immunoglobulins in B-chronic lymphocytic leukaemia
22. Influenza vaccination and mortality from bronchopneumonia in the elderly
23. Abnormal T-cell subpopulation function in CLL: Excessive suppressor (T-gamma) and deficient helper (T-mu) activity with respect to B-cell proliferation
24. Impairments in immune cell function in B cell chronic lymphocytic leukaemia
25. Zanamivir in the prevention of influenza among healthy adults